AMA Ed Hub Logo

Get fast-track DEA training from AMA Ed Hub™
Red JAMA Logo

Learn more on the overdose epidemic from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on the overdose epidemic from PolicyFinder
AMA in Action: Ending the overdose epidemic

End the Epidemic website
Clear Search
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of July 12, 2021

In the news: Johnson & Johnson vaccine and Guillain-Barré, COVID infections doubled in three weeks, CDC reports 29% increase in overdose deaths, additional COVID shots for immunocompromised.

Publications & Newsletters
Copy
·
2 Min Read

Rhode Island is first state to support pilot harm reduction center

AMA strongly supports efforts to reduce drug-related overdose and death.

Press Releases
Copy
Open doors of a cell in a correctional facility or prison.
·
4 Min Read

Require access to Rx for opioid-use disorder in prisons, jails

Delegates seek to ensure that evidence-based treatment for substance-use disorders, along with social support, is available in correctional facilities and upon release.

Population Health
Copy
Naloxone spray
·
3 Min Read

Biden administration boosts access to overdose prevention, treatment

The drug-overdose epidemic continues during the COVID-19 pandemic, but steps are being taken that will save lives and enhance access to treatment.

Behavioral Health
Copy
Pedestrians crossing the street
·
4 Min Read

Removing stigma, advancing evidence-based care at Mount Sinai

Learn about an innovative primary care program at the New York hospital that helps people with opioid-use disorder get the care they need.

Behavioral Health
Copy
·
1 Min Read

AMA statement on FDA decision on naloxone nasal

AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.

Press Releases
Copy
·
4 Min Read

8 keys to end the nation’s drug-overdose epidemic

The CDC is reporting a record-breaking annual toll of nearly 90,000 U.S. overdose deaths. Learn about the policy steps needed to stem the tide.

Behavioral Health
Copy
·
1 Min Read

AMA statement on HHS decision to remove addiction treatment barriers

AMA is pleased that HHS will support physicians to prescribe buprenorphine, will remove daunting regulatory barriers for patients with opioid use disorder.

Press Releases
Copy
·
3 Min Read

April 9, 2021: State Advocacy Update

Kentucky and Virginia enact opioid litigation abatement laws and more in the latest State Advocacy Update.

Advocacy Update
Copy